When large incumbents leave significant but challenging markets, leaner startups can leverage new technologies to drive change. As big pharmaceutical companies shy away from neurological disease research, Verge Genomics founder and CEO Alice Zhang describes how a confluence of technological advances in genomics is creating new opportunities. New nontraditional biotech companies, she observes, are being built by multidisciplinary teams fluent in both biology and computer science.
Related
Claire Hughes Johnson,
Stripe
Scaling Operations and People [Entire Talk]
Build a company that is ready to scale with a strong foundation of values, well-built operating structures, and a complementary team.
Claire Hughes Johnson,
Stripe
Scaling Operations and People [Entire Talk]
Build a company that is ready to scale with a strong foundation of values, well-built operating structures, and a complementary team.
Julia Collins,
Planet FWD
Opportunities in Climate Tech [Entire Talk]
To build a sustainable future, we need to focus on decarbonization - and the climate technology market is ripe with opportunity.
Julia Collins,
Planet FWD
Opportunities in Climate Tech [Entire Talk]
To build a sustainable future, we need to focus on decarbonization - and the climate technology market is ripe with opportunity.
Ben Collier,
The Farmlink Project
James Kanoff,
The Farmlink Project
Students Solving Hunger [Entire Talk]
As mission-driven nonprofits grow, they must stay anchored in their values and strengthen their community.
Ben Collier,
The Farmlink Project
James Kanoff,
The Farmlink Project
Students Solving Hunger [Entire Talk]
As mission-driven nonprofits grow, they must stay anchored in their values and strengthen their community.
